Using real data for a virtual crossmatch

Human Immunology

Volumn 70, Issue 8, 2009, Pages 574-579

  Zachary, Andrea A ^a   Sholander, Jeffrey T ^a   Houp, Julie A ^a   Leffell, Mary S ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ARTICLE; COMPLEMENT DEPENDENT CYTOTOXICITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA ANALYSIS; FLOW CYTOMETRY; HLA MATCHING; IMMUNOASSAY; MEDICAL INFORMATION SYSTEM; PATIENT MONITORING; PHENOTYPE; POSTOPERATIVE CARE; PREDICTION; PRIORITY JOURNAL;

ANTIBODY AFFINITY; COMPLEMENT SYSTEM PROTEINS; CYTOTOXICITY TESTS, IMMUNOLOGIC; FLOW CYTOMETRY; HISTOCOMPATIBILITY; HLA ANTIGENS; HUMANS; IMMUNOSORBENT TECHNIQUES; ISOANTIBODIES; MICROSPHERES; MONITORING, PHYSIOLOGIC; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 68049124774     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2009.06.007     Document Type: Article

References (28)

1. Mickey M.R., Ayoub G., and Terasaki P.I. Prediction of negative cross match: an aid for cost-effective kidney sharing. Transplant Proc 14 (1982) 279-281
2. Oldfather J.W., Anderson C.B., Phelan D.L., Cross D.E., Luger A.M., and Rodey G.E. Prediction of cross match outcome in highly sensitized dialysis patients based on the identification of serum HLA antibodies. Transplantation 42 (1986) 267-270
3. Williams G.M., Hume D.M., Hudson Jr. R.P., Morris P.J., Kano K., and Milgrom F. "Hyperacute" renal-homograft rejection in man. N Engl J Med 279 (1968) 611-618
4. Patel R., and Terasaki P.I. Significance of the positive cross match test in kidney transplantation. N Engl J Med 280 (1969) 735-739
5. Zachary A.A., Montgomery R.A., and Leffell M.S. Defining unacceptable HLA antigens. Curr Opin Organ Transplant 13 (2008) 405-410
6. Zachary A.A., and Leffell M.S. Detecting and monitoring human leukocyte antigen-specific antibodies. Human Immunol 69 (2008) 591-604
7. Appel III J.Z., Hartwig M.G., Cantu III E., Palmer S.M., Reinsmoen N.L., and Davis R.D. Role of flow cytometry to define unacceptable HLA antigens in lung transplant recipients with HLA-specific antibodies. Transplantation 81 (2006) 1049-1057
8. Zangwill S.D., Ellis T.M., Zlotocha J., Jaquiss R.D., Tweddell J.S., Mussatto K.A., and Berger S. The virtual cross match-a screening tool for sensitized pediatric heart transplant recipients. Pediatr Transplant 10 (2006) 38-41
9. Zangwill S., Ellis T., Stendahl G., Zahn A., Berger S., and Tweddell J. Practical application of the virtual cross match. Pediatr Transplant 11 (2007) 650-654
10. Vaidya S. Clinical importance of antihuman leukocyte antigen-specific antibody concentration in performing calculated panel reactive antibody and virtual cross matches. Transplantation 85 (2008) 1046-1050
11. Vaidya S., Partlow D., Susskind B., Noor M., Barnes T., and Gugliuzza K. Prediction of cross match outcome of highly sensitized patients by single and/or multiple antigen bead luminex assay. Transplantation 82 (2006) 1524-1528
12. Tambur A.R., Leventhal J., Kaufman D.B., Friedewald J., Miller J., and Abecassis M.M. Tailoring antibody testing and how to use it in the calculated panel reactive antibody era: the Northwestern University experience. Transplantation 86 (2008) 1052-1059
13. Yang J., Schall C., Smith D., Kreuser L., Zamberlan M., King K., and Gajarski R. HLA sensitization in pediatric pre-transplant cardiac patients supported by mechanical assist devices: the utility of luminex. J Heart Lung Transplant 28 (2009) 123-129
14. Lee P.C., Ozawa M., Hung C.J., Lin Y.J., Chang S.S., and Chou T.C. Reappraisal of HLA antibody analysis and cross matching in kidney transplantation. Transplant Proc 41 (2009) 95-98
15. Muro M., Llorente S., Marín L., Moya-Quiles M.R., Gonzalez-Soriano M.J., Prieto A., et al. Acute vascular rejection mediated by HLA antibodies in a cadaveric kidney recipient: discrepancies between FlowPRA, ELISA and CDC vs luminex screening. Nephrol Dial Transplant 20 (2005) 223-226
16. Zachary A.A., Montgomery R.A., Simpkins C.E., Warren D., and Leffell M.S. Impact of persistent, low levels of donor specific antibody on renal transplants. Am J Transplant 5 S11 (2005) 245
17. Hopkins K.A. The basic lymphocyte microcytotoxicity tests: standard and AHG enhancement. In: Hahn A.B., Land G.A., and Strothman R.M. (Eds). The ASHI laboratory manual. 4th ed. (2000), The American Society for Histocompatibility and Immunogenetics, Mt. Laurel, NJ p 1.C.1.1-1.C.1.5.
18. Zachary A.A., Delaney N.L., Lucas D.P., and Leffell M.S. Characterization of HLA class I specific antibodies by ELISA using solubilized antigen targets. I. Evaluation of the GTI QuikID assay and analysis of antibody patterns. Human Immunol 62 (2001) 228-235
19. Vega R., Trujillo O., Sikorski P., Houp J., Sholander J., Zachary A.A., et al. A new fully-automated solid-phase assay for HLA-specific antibodies. Hum Immunol 68 (2008) S78
20. Idica AK, Kaneku HK, Sasaki N, Rebellato LM, Terasaki PI. Denatured and intact HLA specific antibody in transplantation. Abstract accepted for poster presentation, American Transplant Congress, May 31, 2009. (http://www.abstracts2view.com/atc/view). Accessed April 6, 2009.
21. Zachary A.A., Lucas D.P., Detrick B., and Leffell M.S. Naturally occurring interference in luminex® assays for HLA-specific antibodies: characteristics and resolution. Human Immunol (2009) April 11 [Epub ahead of print]
22. Warner P.R., Youngs D., and Nelson K.A. HLA density on microparticles versus antibody detection sensitivity: implications for cross match prediction. Hum Immunol 68 (2007) S28
23. Bielmann D., Honger G., Lutz D., et al. Pretransplant risk assessment in renal allograft recipients using virtual cross matching. Am J Transplant 7 (2007) 626-632
24. Bingaman A.W., Murphey C.L., Palma-Vargas J., and Wright F. A virtual cross match protocol significantly increases access of highly sensitized patients to deceased donor kidney transplantation. Transplantation 86 (2008) 1864-1868
25. Tait B.D., Hudson F., Cantwell L., Brewin G., Holdsworth R., Bennet G., and Jose M. Luminex technology for HLA antibody detection in organ transplantation. Nephrology 14 (2009) 247-254
26. Reinsmoen N.L., Lai C., Vo A., et al. Acceptable donor-specific antibody levels allowing for successful deceased and living donor kidney transplantation after desensitization therapy. Transplantation 86 (2008) 820-825
27. Leffell M.S., and Zachary A.A. The role of the histocompatibility laboratory in desensitization for transplantation. Curr Opin Organ Transplant (2009) May 4 [Epub ahead of print]
28. Locke J.E., Zachary A.A., Warren D.S., Segev D.L., Houp J.A., Montgomery R.A., et al. Proinflammatory events are associated with significant increases in breadth and strength of HLA-specific antibody. Am J Transplant (2009) in press